Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-08

Clinical Trial Update: Renal Retention in High Grade Upper Tract Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Johns Hopkins is recruiting to evaluate treatment for high-grade upper tract urothelial carcinoma and bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: High Grade Urothelial Carcinoma, Bladder Cancer | Phase 2 | Status: RECRUITING